Forest Laboratories Inc (FRX.N)

FRX.N on New York Stock Exchange

44.84USD
11:36am EDT
Price Change (% chg)

$0.18 (+0.40%)
Prev Close
$44.66
Open
$44.60
Day's High
$44.91
Day's Low
$44.53
Volume
57,606
Avg. Vol
411,948
52-wk High
$44.91
52-wk Low
$31.72

FRX.N

Chart for FRX.N

About

Forest Laboratories, Inc. (Forest) develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. Its products include... (more)

Overall

Beta: 0.77
Market Cap (Mil.): $11,968.12
Shares Outstanding (Mil.): 267.98
Dividend: --
Yield (%): --

Financials

  FRX.N Industry Sector
P/E (TTM): -- 38.06 37.87
EPS (TTM): -0.24 -- --
ROI: -- 19.42 18.70
ROE: -- 20.10 19.53
Search Stocks

UPDATE 4-U.S. drugmaker Perrigo to buy Ireland's Elan for $8.6 bln

DUBLIN, July 29 - U.S. drugmaker Perrigo agreed to buy Elan for $8.6 billion in a deal that will hand it tax savings from being domiciled in Ireland and royalties from a blockbuster multiple sclerosis treatment.

29 Jul 2013

REFILE-Deals of the day -- mergers and acquisitions

July 25 - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday:

25 Jul 2013

UPDATE 1-Market Chatter-Corporate finance press digest

July 25 - The following corporate finance-related stories were reported by media on Thursday:

25 Jul 2013

Market Chatter-Corporate finance press digest

July 25 - The following corporate finance-related stories were reported by media on Thursday:

25 Jul 2013

Elan seeks bids from Allergan, Forest: sources

NEW YORK - Irish drugmaker Elan Corp is seeking first-round bids next week after drawing interest from a few drugmakers including Allergan Inc and Forest Laboratories Inc , several people familiar with the matter said on Friday.

12 Jul 2013

UPDATE 1-Elan seeks bids from Allergan, Forest -sources

NEW YORK, July 12 - Irish drugmaker Elan Corp is seeking first-round bids next week after drawing interest from a few drugmakers including Allergan Inc and Forest Laboratories Inc, several people familiar with the matter said on Friday.

12 Jul 2013

First-round bids for Elan due next week -sources

NEW YORK, July 12 - Elan Corp is seeking first-round bids next week after drawing interest from a few drugmakers including Allergan Inc and Forest Laboratories Inc, several people familiar with the matter said on Friday.

12 Jul 2013

Forest Labs says trial results positive for hypertension drug

June 27 - Forest Laboratories Inc said on Thursday that combining Bystolic, the brand name for nebivolol, and valsartan to treat hypertension in a clinical trial was more effective at lowering blood pressure than either nebivolol or valsartan alone at eight weeks.

27 Jun 2013

Wall St. plunges, S&P posts biggest drop since Nov 2011

NEW YORK - Stocks fell more than 2 percent on Thursday, extending the previous day's sharp decline as investors fretted over the Federal Reserve's plan to begin reducing its stimulus later this year if the economy strengthens. | Video

20 Jun 2013

US STOCKS-Wall Street drops in wake of Fed stimulus wind-down plan

NEW YORK, June 20 - The Federal Reserve's plans to begin winding down its massive monetary stimulus later this year hurt shares on Wall Street for a second day Thursday, putting the S&P on track for its worst two-day run in seven months.

20 Jun 2013

Competitors

  Price Change
Pfizer Inc. (PFE.N) $29.27 +0.16
Johnson & Johnson (JNJ.N) $94.02 +0.25
Novartis AG (NOVN.VX) CHF67.55 +0.95
Roche Holding Ltd. (ROG.VX) CHF228.70 +0.70
Abbott Laboratories (ABT.N) $36.85 +0.01
AstraZeneca plc (AZN.L) 3,332.50p -1.50
GlaxoSmithKline plc (GSK.L) 1,712.50p 0.00
Eli Lilly & Co. (LLY.N) $53.65 +0.15
Teva Pharmaceutical Industries Limited (TEVA.TA) 13,920.00₪ -200.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$58.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$495.00
Provider: MacroRisk Analytics/EconomicInvestor
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks